1) Akiskal HS, Benazzi F, Perugi G, et al:Agitated “unipolar” depression re-conceptualized as a depressive mixed state:Implications for the antidepressant-suicide controversy. J Affect Disord 85:245-258, 2005
2) Kennedy SH, Lam RW, Parikh SV, et al:Canadian Network for Mood and Anxiety Treatments(CANMAT)clinical guidelines for the management of major depressive disorder in adults. J Affect Disord 117(supple 1):S1-S2, 2009
3) 原田豪人,坂元薫:中等症・重症うつ病に対するガイドラインの課題.臨床精神薬理 16:991-998, 2013
4) Kraepelin E:Psychiatrie Ein Lehrbuch für Studierende und Arzte Achten Auflage. Johann Ambrosius Barth, Leibzig, 1916
5) Leonhard K:Karl Leonhard Classification of Endgenous Psychoses and their Differentiated Etiology, 2nd English ed. Springer-Ver-lag, Wien, 1999(福田哲雄,岩波明,林拓二訳:内因性精神病の分類.医学書院,2002)
6) Palmer HD, Sherman SH:The involutional melancholia process. Arch Neurol Psychiatry 40:762-788, 1938
7) Rosenthal SH:The involutional depressive syndrome. Am J Psychiatry 124:21-34, 1968
8) 佐藤晋爾,朝田隆:操作的診断の中で見失われがちな,大切な疾病概念や症状の再評価シリーズ 激越型うつ病.精神医学 55:571-574, 2013
9) The American Psychiatric Association:Clinical Practice Guidelines for Depression, 2011
10) Ereshefsky L:The Texas Medication Algorithm Project for major depression. Manag Care 10(supple 8):16-17, discussion 18-22, 2001
11) Watanabe N, Omori IM, Nakagawa A, et al:Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression:Systematic review and meta-analysis. J Clin Psychiatry 69:1404-1415, 2008
12) Watanabe N, Omori IM, Nakagawa A, et al:Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression:Systematic review and meta-analysis. CNS Drugs 24:35-53, 2010
13) Weisman MM:The myth of involutional melancholia. JAMA 242:742-744, 1979
14) Weygandt W:Uber die Mischzustande des manisch-depressiven Irreseins. Lehmann, München, 1899